Herpes simplex virus: An important etiology for secondary glaucoma

International Ophthalmology Clinics

Volumn 47, Issue 2, 2007, Pages 99-107

  Jones III, Relief ^a   Pasquale, Louis R ^a   Pavan Langston, Deborah ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; CARBONATE DEHYDRATASE INHIBITOR; CORTICOSTEROID; FAMCICLOVIR; IDOXURIDINE; LATANOPROST; PLACEBO; PROSTAGLANDIN; STEROID; TIMOLOL; TRIFLURIDINE; VALACICLOVIR; VIDARABINE;

ADD ON THERAPY; CLINICAL FEATURE; CORNEA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; EYE DISEASE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; IRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SECONDARY GLAUCOMA; SIDE EFFECT; VIRUS REACTIVATION; VIRUS TRANSMISSION;

GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; KERATITIS, HERPETIC; OCULAR HYPERTENSION; SIMPLEXVIRUS; UVEITIS;

EID: 34248180070     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3180377632     Document Type: Review

References (40)

1. Pavan-Langston D. Viral disease of the ocular anterior segment: basic science and clinical disease. In: Foster S, Azar D, Dohlman C, eds. Smolin and Thoft's the Cornea: Scientific Foundations and Clinical Practice. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:297-397.
2. Kimura SJ. Herpes simplex uveitis: a clinical and experimental study. Tr Am Ophth Soc. 1962;60:440-470.
3. Witmer R, Iwamoto T. Electron microscope observation of herpes-like particles in the iris. Arch Ophthal. 1968;79:331-337.
4. Sundmacher R, Neumann-Haefelin D. Herpes simplex virus isolations from the aqueous of patients suffering from focal iritis, endotheliitis, and prolonged disciform keratitis with glaucoma. Klin Monatsbl Augenheilkd. 1979;175:488-501.
5. Pavan-Langston D, Brockhurst RJ. Herpes simplex panuveitis. Arch Ophthal. 1969;81:783-787.
6. Falcon MG, Williams HP. Herpes simplex keratouveitis and glaucoma. Trans Ophthal Soc UK. 1978;98:101-104.
7. Thygeson P. Chronic herpetic keratouveitis. Tr Am Ophth Soc. 1967;65:211-226.
8. Hogan MJ, Kimura SJ, Thygeson P. Pathology of herpes simplex keratouveitis. Tr Am Ophth Soc. 1963;61:75-99.
9. Townsend WM, Kaufman HE. Pathogenesis of glaucoma and endothelial changes in herpetic keratouveitis in rabbits. Am J Ophthalmol. 1971;71:904-910.
10. Pavan-Langston D, Nelson DJ. Intraocular penetration of trifluridine. Am J Ophthalmol. 1979;87:814-818.
11. Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. Arch Ophthalmol. 1996;114:1065-1072.
12. Wilhelmus KR, Dawson CR, Barron BA, et al. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Br J Ophthalmol. 1996;80:969-972.
13. Barron BA, Gee L, Hauck WW. Herpetic Eye Disease Study: a controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101:1871-1882.
14. Wilhelmus KR, Gee L, Hauck WW. Herpetic Eye Disease Study: a controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 1994;101:1883-1896.
15. Dawson CR. The Herpetic Eye Disease Study. Arch Ophthalmol. 1990;108:191-192.
16. The Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med. 1998;339:300-306.
17. Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis. Arch Ophthalmol. 1997;115:703-712.
18. Posner A, Schlossman A. Syndrome of unilateral recurrent attacks of glaucoma with cyclitis symptoms. Arch Ophthalmol. 1948;39:517-535.
19. Levatin P. Glaucomatocyclitic crisis occurring in both eyes. Am J Ophthalmol. 1956;41:1056.
20. Spivey BE, Armaly MF. Tonographic findings in glaucomatocyclitic crisis. Am J Ophthalmol. 1963;55:47-51.
21. Hung PT, Chang JM. Treatment of glaucomatocyclitic crisis. Am J Ophthalmol. 1974;77:169.
22. Raitta C, Vannas A. Glaucomatocyclitic crisis. Arch Ophthalmol. 1977;95:608-612.
23. Kass MA, Becker B, Kolker AE. Glaucomatocyclitic crisis and primary open-angle glaucoma [Case report]. Am J Ophthalmol. 1973;75:668-673.
24. Jap A, Sivakumar M, Chee S. Is Posner Schlossman syndrome benign? Am J Ophthalmol. 2001;108:913-918.
25. Weinreb RN. Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. Ophthalmology. 1987;94:564-570.
26. Stavrou P, Murray PI. Does trabeculectomy influence the course of uveitis? Ocul Immunol Inflamm. 1999;7:103-108.
27. Hill RA, Nguyen QH, Baerveldt G, et al. Trabeculectomy and Molteno implantation for glaucomas associated with uveitis. Ophthalmology. 1993;100:903-908.
28. Bloch-Michel E, Dussaix E, Cerqueti P, et al. Possible role of cytomegalovirus infection in the etiology of the Posner-Schlossman syndrome. Int Ophthalmol. 1987;11:95-96.
29. Tanaka Y, Harino S, Hara J. Cellular immunity as judged by varicella skin test in Posner-Schlossman syndrome patients. Folia Jpn. 1985;36:972-976.
30. Yamamoto S, Pavan-Langston D, Tada R, et al. Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome. Am J Ophthalmol. 1995;119:796-798.
31. Hill JM, Shimomura Y, Dudley JB, et al. Timolol induces HSV-1 ocular shedding in the latently infected rabbit. Invest Ophthalmol Vis Sci. 1987;28:585-590.
32. Deai T, Fukuda M, Hibino T, et al. Herpes simplex virus genome quantification in two patients who developed herpetic epithelial keratitis during treatment with antiglaucoma medications. Cornea. 2004;23:125-128.
33. Wand M, Gilbert CM, Liesegang TJ. Latanoprost and herpes simplex keratitis. J Ophthalmol. 1999;127:602-604.
34. Kaufman HE, Varnell ED, Thompson HW. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit. Am J Ophthalmol. 1999;127:531-536.
35. Kaufman HE, Varnell ED, Toshida H, et al. Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit. Am J Ophthalmol. 2001;131:643-646.
36. Ekatomatis P. Herpes simplex dendritic keratitis after treatment with latanoprost for primary open angle glaucoma. Br J Ophthalmol. 2001;85:1008-1009.
37. Gordon YJ, Yates KA, Mah FS, et al. The effects of xalatan on the recovery of ocular herpes simplex virus type 1 in the induced reactivation and spontaneous shedding rabbit models. J Ocul Pharmacol Ther. 2003;19:233-245.
38. Kroll DM, Schuman JS. Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma. Am J Ophthalmol. 2002;133:401-403.
39. Bean G, Reardon G, Zimmerman TJ. Association between ocular herpes simplex virus and topical ocular hypotensive therapy. J Glaucoma. 2004;13:361-364.
40. Camras CB. Latanoprost increase the severity and recurrence of herpetic keratitis in the rabbit: latanoprost and herpes simplex keratitis. Am J Ophthalmol. 2000;129:271-272.